Unicycive Therapeutics News

Benchmark: Restated Unicycive Therapeutics (UNCY.US) rating and adjusted from Speculative Buy to Specified Buy, target price of $3.00.

Zhitong FinanceApr 15 23:00

Unicycive Therapeutics Analyst Ratings

BenzingaApr 15 22:57

Buy Rating Affirmed for Unicycive Therapeutics on Strong Trial Progress and Financial Positioning

TipRanksApr 12 03:05

Unicycive Therapeutics Analyst Ratings

BenzingaApr 4 19:02

Unicycive Therapeutics Analyst Ratings

BenzingaApr 1 18:15

HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $4.5 Price Target

BenzingaApr 1 18:16

Unicycive Therapeutics Analyst Ratings

BenzingaMar 14 18:45

HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $4.5 Price Target

BenzingaMar 14 18:48

Unicycive Therapeutics Analyst Ratings

BenzingaMar 8 20:15

Unicycive Therapeutics Analyst Ratings

BenzingaMar 5 20:04

Unicycive Therapeutics Analyst Ratings

BenzingaFeb 15 01:48

Unicycive Therapeutics: Promising Pipeline and Positive Buy Rating Amidst Developmental Milestones

TipRanksJan 24 00:15

HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $4.5 Price Target

BenzingaDec 19, 2023 19:27

Unicycive Therapeutics Analyst Ratings

BenzingaDec 19, 2023 19:26

Strong Buy Rating for Unicycive Therapeutics Amidst Clinical Advances and Positive Valuation Outlook

TipRanksDec 19, 2023 19:16

Benchmark Reiterates Speculative Buy on Unicycive Therapeutics, Maintains $3 Price Target

BenzingaDec 4, 2023 22:59

Unicycive Therapeutics Analyst Ratings

BenzingaDec 4, 2023 22:58

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Icecure Medical (ICCM) and Unicycive Therapeutics (UNCY)

TipRanksNov 16, 2023 19:30

Unicycive Therapeutics' Promising Pathway to FDA Approval: An Analysis of Arce's Buy Rating

TipRanksOct 23, 2023 23:05

HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $4.5

BenzingaAug 16, 2023 18:39